PNC Financial Services Group Inc. Decreases Stock Holdings in iShares Biotechnology ETF $IBB

Posted by Kyle Jackson on Jul 24th, 2026

PNC Financial Services Group Inc. lowered its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 318,588 shares of the financial services provider’s stock after selling 6,394 shares during the quarter. PNC Financial Services Group Inc. owned 0.67% of iShares Biotechnology ETF worth $53,794,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also bought and sold shares of IBB. Darwin Wealth Management LLC bought a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at about $25,000. Basepoint Wealth LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter worth about $26,000. Cary Street Partners Financial LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $29,000. Copia Wealth Management bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $34,000. Finally, Caitlin John LLC bought a new stake in iShares Biotechnology ETF during the fourth quarter worth approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of IBB stock opened at $188.98 on Friday. iShares Biotechnology ETF has a 1 year low of $130.25 and a 1 year high of $199.05. The stock’s 50 day simple moving average is $179.10 and its two-hundred day simple moving average is $173.95.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, June 18th. Stockholders of record on Monday, June 15th were given a dividend of $0.0238 per share. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a dividend yield of 0.1%.

iShares Biotechnology ETF Company Profile

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.